ArticleFrontiers in immunology2018

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9.

Hao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.